Related Experiment Video
Updated: Sep 30, 2026

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
A novel mechanism for the regulation of amyloid precursor protein metabolism
Qi Chen1, Hideo Kimura, David Schubert
1Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.
Abstract:
Modifier of cell adhesion protein (MOCA; previously called presenilin [PS] binding protein) is a DOCK180-related molecule, which interacts with PS1 and PS2, is localized to brain areas involved in Alzheimer's disease (AD) pathology, and is lost from the soluble fraction of sporadic Alzheimer's disease (AD) brains. Because PS1 has been associated with gamma-secretase activity, MOCA may be involved in the regulation of beta-amyloid precursor protein (APP) processing. Here we show that the expression of MOCA decreases both APP and amyloid beta-peptide secretion and lowers the rate of cell-substratum adhesion. In contrast, MOCA does not lower the secretion of amyloid precursor-like protein (APLP) or several additional type 1 membrane proteins. The phenotypic changes caused by MOCA are due to an acceleration in the rate of intracellular APP degradation. The effect of MOCA expression on the secretion of APP and cellular adhesion is reversed by proteasome inhibitors, suggesting that MOCA directs nascent APP to proteasomes for destruction. It is concluded that MOCA plays a major role in APP metabolism and that the effect of MOCA on APP secretion and cell adhesion is a downstream consequence of MOCA-directed APP catabolism. This is a new mechanism by which the expression of APP is regulated.
Insights
Modifier of cell adhesion protein (MOCA) reduces amyloid precursor protein (APP) secretion and cell adhesion by targeting APP for proteasomal degradation. This discovery reveals a novel mechanism regulating APP expression, potentially impacting Alzheimer's disease (AD) pathology.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Modifier of cell adhesion protein (MOCA) interacts with presenilin (PS) proteins, implicated in Alzheimer's disease (AD).
- MOCA is localized to AD-affected brain regions and reduced in sporadic AD brains.
- PS1's association with gamma-secretase suggests MOCA's role in beta-amyloid precursor protein (APP) processing.
Purpose of the Study:
- To investigate the role of MOCA in APP processing and cell adhesion.
- To elucidate the mechanism by which MOCA affects APP secretion and cellular behavior.
Main Methods:
- Assessed the impact of MOCA expression on APP and amyloid beta-peptide secretion.
- Measured cell-substratum adhesion rates.
- Investigated the effect of MOCA on amyloid precursor-like protein (APLP) secretion.
- Utilized proteasome inhibitors to explore the degradation pathway of APP.
Main Results:
- MOCA expression decreased both APP and amyloid beta-peptide secretion.
- MOCA reduced cell-substratum adhesion rates.
- MOCA did not affect the secretion of APLP or other type 1 membrane proteins.
- Phenotypic changes were attributed to accelerated intracellular APP degradation via proteasomes.
- Proteasome inhibitors reversed MOCA's effects on APP secretion and cell adhesion.
Conclusions:
- MOCA plays a significant role in APP metabolism.
- MOCA directs nascent APP to proteasomes for degradation, a novel regulatory mechanism.
- MOCA's effects on APP secretion and cell adhesion are downstream consequences of APP catabolism.
- This mechanism offers new insights into APP expression regulation and potential AD therapeutic targets.
Related Concept Videos
Protein Folding Quality Check in the RER
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Inborn Errors of Metabolism
Oligosaccharide Assembly
Multiple sugar molecules that may or may...
Biosynthesis of Nucleic Acids
Biosynthesis of Polysaccharides

